标题
Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients
作者
关键词
Cisplatin, Hypoxic tumors, Drug resistance, Chemosensitizers, Tumor oxygenation
出版物
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 162, Issue -, Pages 103327
出版商
Elsevier BV
发表日期
2021-04-21
DOI
10.1016/j.critrevonc.2021.103327
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers
- (2019) Marijke Zonneveld et al. Cancers
- Hypoxic non-small-cell lung cancer cell-derived exosomal miR-21 promotes resistance of normoxic cell to cisplatin
- (2019) Caijun Dong et al. OncoTargets and Therapy
- HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity
- (2019) Basmina Parmakhtiar et al. MOLECULAR CANCER RESEARCH
- Circulating MicroRNAs in Cancer: Potential and Challenge
- (2019) Mengying Cui et al. Frontiers in Genetics
- Mitochondrial fission causes cisplatin resistance under hypoxic conditions via ROS in ovarian cancer cells
- (2019) Youngjin Han et al. ONCOGENE
- Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia
- (2019) Devarajan Nalini et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- The cisplatin-based Pt(iv)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions
- (2018) Elisabetta Gabano et al. DALTON TRANSACTIONS
- Scutellaria baicalensis targets the hypoxia-inducible factor-1α and enhances cisplatin efficacy in ovarian cancer
- (2018) Imran Hussain et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins
- (2018) Kalpana Deepa Priya Dorayappan et al. ONCOGENE
- The role of HIF-1α in chemo-/radioresistant tumors
- (2018) Yu Xia et al. OncoTargets and Therapy
- A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells
- (2018) Eroje M. Ahmed et al. CELLULAR ONCOLOGY
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
- (2018) Christophe Deben et al. Cancers
- The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer
- (2018) Xiaoliang Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Role of HIF-1 in Cancer Progression: Novel Insights. A Review
- (2018) Aldo Pezzuto et al. CURRENT MOLECULAR MEDICINE
- Hypoxia-activated prodrugs and redox-responsive nanocarriers
- (2018) Yun Zeng et al. International Journal of Nanomedicine
- Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
- (2018) Chao-Yue Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α
- (2017) Yue Pan et al. International Journal of Biological Sciences
- Independent Prognostic Value of Hypoxia-inducible Factor 1-alpha Expression in Small Cell Lung Cancer
- (2017) Chang-Sheng Lin et al. International Journal of Medical Sciences
- Hypoxia/IL-1α axis promotes gastric cancer progression and drug resistance
- (2017) Yi Xuan et al. Journal of Digestive Diseases
- Pharmacological effects of asiatic acid in glioblastoma cells under hypoxia
- (2017) Flourina Kumar Thakor et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α
- (2017) Xue Feng et al. OncoTargets and Therapy
- A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma
- (2017) Xiang Qi et al. Oncotarget
- MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer
- (2017) Giuseppina Roscigno et al. Oncotarget
- Overcoming cisplatin resistance in osteosarcoma through the miR-199a-modulated inhibition of HIF-1α
- (2017) Ajimu Keremu et al. BIOSCIENCE REPORTS
- Expression of adenosine receptors and vegf during angiogenesis and its inhibition by pentoxifylline—A study using zebrafish model
- (2016) Jhansi Rani Nathan et al. BIOMEDICINE & PHARMACOTHERAPY
- Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer
- (2016) Fuquan Zhang et al. CANCER SCIENCE
- Plant-Derived Agents for Counteracting Cisplatin-Induced Nephrotoxicity
- (2016) Shreesh Ojha et al. Oxidative Medicine and Cellular Longevity
- Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells
- (2016) Shrikant Pradhan et al. Oncotarget
- MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer
- (2016) Xiaoxiao Ge et al. Oncotarget
- Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia
- (2016) Jhih-Pu Syu et al. Oncotarget
- Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms
- (2015) Guifang Yu et al. Cancer Cell International
- Cyclometalated Ruthenium(II) Anthraquinone Complexes Exhibit Strong Anticancer Activity in Hypoxic Tumor Cells
- (2015) Leli Zeng et al. CHEMISTRY-A EUROPEAN JOURNAL
- Role of mismatch repair proteins in the processing of cisplatin interstrand cross-links
- (2015) Akshada Sawant et al. DNA REPAIR
- Sulforaphane reduces molecular response to hypoxia in ovarian tumor cells independently of their resistance to chemotherapy
- (2015) MICHAL PASTOREK et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization
- (2015) Carina Fischer et al. Molecular Cancer
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- HIF-1 Signaling in Drug Resistance to Chemotherapy
- (2014) N.A. Warfel et al. CURRENT MEDICINAL CHEMISTRY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Survivin as a Preferential Target for Cancer Therapy
- (2014) Mahsa Mobahat et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Phase III Randomized Trial of Weekly Cisplatin and Irradiation Versus Cisplatin and Tirapazamine and Irradiation in Stages IB2, IIA, IIB, IIIB, and IVA Cervical Carcinoma Limited to the Pelvis: A Gynecologic Oncology Group Study
- (2014) Paul A. DiSilvestro et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple functions of hypoxia-regulated miR-210 in cancer
- (2014) Qin Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells
- (2014) Hai-Shan Peng et al. PLoS One
- Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer
- (2014) Oscar Arrieta et al. RADIOTHERAPY AND ONCOLOGY
- Imaging Tumor Hypoxia to Advance Radiation Oncology
- (2013) Chen-Ting Lee et al. ANTIOXIDANTS & REDOX SIGNALING
- Targeting mitochondria by α-tocopheryl succinate overcomes hypoxia-mediated tumor cell resistance to treatment
- (2013) Andrey V. Kulikov et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer
- (2013) Xue-Pu Sun et al. FEBS Journal
- p53 restoration can overcome cisplatin resistance through inhibition of Akt as well as induction of Bax
- (2013) CHAE WON KIM et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- An Overview of Cyclophilins in Human Cancers
- (2013) J Lee et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Hypoxia–Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
- (2013) Jennifer Adamski et al. PLoS One
- Quercetin enhances hypoxia-mediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer
- (2012) Hak-Su Kim et al. APOPTOSIS
- Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)
- (2012) Prabodh K Kandala et al. BMC Medicine
- Chemotherapeutic Sensitivity of Testicular Germ Cell Tumors Under Hypoxic Conditions Is Negatively Regulated by SENP1-Controlled Sumoylation of OCT4
- (2012) Y.-C. Wu et al. CANCER RESEARCH
- Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cellsin vivo
- (2012) Sutapa Sinha et al. INTERNATIONAL JOURNAL OF CANCER
- Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia
- (2012) Makoto Shimanishi et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Hypoxia-Inducible Factor-1α and Excision Repair Cross-Complementing 1 in Patients with Small Cell Lung Cancer Who Received Front-Line Platinum-Based Chemotherapy: A Retrospective Study
- (2012) Gyeong-Won Lee et al. Journal of Thoracic Oncology
- Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells
- (2012) LI JIANG et al. Molecular Medicine Reports
- Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4
- (2011) Saskia E Rademakers et al. BMC CANCER
- Role of cyclophilin B in tumorigenesis and cisplatin resistance in hepatocellular carcinoma in humans
- (2011) Yeonghwan Kim et al. HEPATOLOGY
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Novel combinational treatment of cisplatin with cyclophilin a inhibitors in human heptocellular carcinomas
- (2010) Jinhwa Lee ARCHIVES OF PHARMACAL RESEARCH
- Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: The mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1
- (2010) Xin-zhi Huang et al. CANCER BIOLOGY & THERAPY
- Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
- (2010) Danny Rischin et al. JOURNAL OF CLINICAL ONCOLOGY
- An Akt/Hypoxia-Inducible Factor-1 /Platelet-Derived Growth Factor-BB Autocrine Loop Mediates Hypoxia-Induced Chemoresistance in Liver Cancer Cells and Tumorigenic Hepatic Progenitor Cells
- (2009) C. K. Lau et al. CLINICAL CANCER RESEARCH
- Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
- (2009) S. L. C. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells
- (2008) J Hao et al. CANCER GENE THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search